Amalgamated Bank buys 71 shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Amalgamated Bank increased its position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 0.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,347 shares of the biotechnology company’s stock after acquiring an additional 71 shares during the period. Amalgamated Bank’s holdings in Axon Enterprise were worth $4,516,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the company. Avantax Advisory Services Inc. raised its stake in Axon Enterprise by 0.8% in the first quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock valued at $1,659,000 after purchasing an additional 40 shares in the last quarter. Brookstone Capital Management boosted its holdings in shares of Axon Enterprise by 5.1% in the first quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock worth $263,000 after acquiring an additional 41 shares during the last quarter. CWM LLC raised its stake in shares of Axon Enterprise by 1.5% in the second quarter. CWM LLC now owns 2,820 shares of the biotechnology company’s stock valued at $830,000 after acquiring an additional 43 shares during the period. Wealthspan Partners LLC boosted its holdings in Axon Enterprise by 4.9% in the second quarter. Wealthspan Partners LLC now owns 965 shares of the biotechnology company’s stock valued at $284,000 after buying an additional 45 shares in the last quarter. Finally, Burns Matteson Capital Management LLC boosted its position in Axon Enterprise by 6.7% in the second quarter. Burns Matteson Capital Management LLC now owns 730 shares of the biotechnology company’s stock worth $215,000 after purchasing an additional 46 shares during the period. 79.08% of shares are currently owned by institutional investors and hedge funds.

Analysts set new price targets

A number of analysts have recently issued reports on AXON shares. Barclays upped their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Craig Hallum upped their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Jefferies Financial Group began coverage on Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target on the stock. Northland Securities upped their price target on Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Finally, Robert W. Baird boosted their price objective on Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research report on Tuesday, 10 September. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus price target of $365.38, according to MarketBeat.com.

Check out our latest report on Axon Enterprise

Axon Enterprise Trading Up 0.9%

AXON opened at $393.29 on Friday. The stock has a market cap of $29.72 billion, a price-to-earnings ratio of 115.00, a P/E/G ratio of 10.34 and a beta of 0.94. The company has a quick ratio of 2.52, a current ratio of 2.88, and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a 12-month low of $189.12 and a 12-month high of $393.58. The company has a 50-day simple moving average of $348.04 and a 200-day simple moving average of $317.22.

Axon Enterprise (NASDAQ:AXON – Get Your Free Report ) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. The company had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company’s quarterly revenue was up 34.5% year over year. In the same quarter last year, the firm posted EPS of $0.80. Analysts predict that Axon Enterprise, Inc. will record 1.79 EPS for the current fiscal year.

Insiders place their bets

In other news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $380.99, for a total value of $380,990.00. Following the transaction, the director now owns 27,259 shares in the company, valued at approximately $10,385,406.41. The sale was disclosed in a filing with the SEC, which is available on the SEC’s website. In related news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the transaction, the chief executive officer now owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. The sale was disclosed in a legal filing with the SEC, which is available on the SEC’s website. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $380.99, for a total transaction of $380,990.00. Following the sale, the director now directly owns 27,259 shares in the company, valued at approximately $10,385,406.41. The disclosure for this sale can be found here. Insiders have sold 317,981 shares of company stock worth $115,662,734 over the last three months. Insiders own 6.10% of the company’s shares.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors and TASER. The company also provides cloud-based hardware and software solutions that enable law enforcement to capture, securely store, manage, share and analyze video and other digital evidence.

Further reading

Want to see what other hedge funds own AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).

Get news and reviews for Axon Enterprise Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axon Enterprise and related companies with MarketBeat.com’s FREE daily email newsletter.